Expensify, Inc.

For the period ended Dec 31, 2025. Filed Feb 26, 2026.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Feb 26, 2026

EXFY$1.85-9.8%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Statements of Changes in Stockholders’ Equity

Preferred stock · Common stock · Additional paid-in capital · Accumulated deficit · Total stockholders' equity
Shares · Amount · Shares · Amount
Balance at December 31, 2023	—	$—	85,225,328	$8	$241,509	$(140,773)	$100,744
Issuance of common stock upon exercise of stock options, net of shares exchanged for payment	—	—	1,915,660	—	431	—	431
Vesting of early exercised stock options	—	—	—	—	426	—	426
Issuance of restricted stock units	—	—	35,808	—	70	—	70
Repurchases of early exercised stock options	—	—	(32,954)	—	—	—	—
Issuance of common stock under Matching Plan	—	—	4,084,514	1	4,090	—	4,091
Issuance of common stock in connection with restricted stock units vesting	—	—	1,441,804	—	—	—	—
Shares withheld from common stock issued to pay employee payroll taxes	—	—	(647,457)	—	(2,179)	—	(2,179)
Repurchase and retirement of common stock	—	—	(645,938)	—	(1,510)	—	(1,510)
Stock-based compensation	—	—	—	—	36,225	—	36,225
Net loss	—	—	—	—	—	(10,055)	(10,055)
Balance at December 31, 2024	—	$—	91,376,765	$9	$279,062	$(150,828)	$128,243
Issuance of common stock upon exercise of stock options	—	—	361,924	—	323	—	323
Vesting of early exercised stock options	—	—	—	—	113	—	113
Issuance of restricted stock units	—	—	11,218	—	33	—	33
Settlement of liability-classified restricted common shares	—	—	628,359	—	—	—	—
Issuance of common stock under Matching Plan	—	—	4,493,975	—	6,321	—	6,321
Issuance of common stock in connection with restricted stock units vesting	—	—	1,011,779	—	—	—	—
Repurchase and retirement of common stock	—	—	(4,823,118)	—	(9,095)	—	(9,095)
Stock-based compensation	—	—	—	—	28,196	—	28,196
Net loss	—	—	—	—	—	(21,389)	(21,389)
Balance at December 31, 2025	—	$—	93,060,902	$9	$304,953	$(172,217)	$132,745

The accompanying notes are an integral part of these consolidated financial statements.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.